Skip to main content

Table 3 Characteristics and imaging studies of peripheral arterial disease in polymyalgia rheumatica (PMR) and non-PMR cohorts

From: Increased risk of peripheral arterial disease in polymyalgia rheumatica: a population-based cohort study

Variable

Non-PMR cohort (n = 28)

PMR cohort (n = 38)

P value

Claudication symptoms

28 (100%)

38 (100%)

 

Dorsalis pedis pulse

  

0.09

   Abnormal

24 (92%)

37 (100%)

 

   Normal

2 (8%)

0 (0%)

 

Noninvasive arterial study done

17 (61%)

19 (50%)

0.39

Ankle-brachial index < 0.90 in either leg

13 (76%)

17 (89%)

0.30

Computed tomography angiogram done

12 (43%)

5 (13%)

0.006

Magnetic resonance angiogram done

8 (29%)

3 (8%)

0.026

Conventional angiogram done

11 (39%)

6 (16%)

0.031

Any vascular imaging done

14 (50%)

8 (21%)

0.014

Stenosis on imaging

  

0.08

   Yes

5 (36%)

6 (75%)

 

   No

9 (64%)

2 (25%)

 

Revascularization for peripheral arterial disease

9 (32%)

4 (11%)

0.038

Percutaneous intervention/stent

2 (7%)

0 (0%)

0.09

Vascular bypass surgery

6 (22%)

4 (11%)

0.21

Amputation for peripheral arterial disease

2 (7%)

1 (3%)

0.40

  1. Data presented as n (%).